VRTX Latest Headlines

Vertex Highlights -42.7% UACR Reduction With Inaxaplin in AMKD Modest Proteinuria Cohort as AMPLITUDE Enrollment Wraps

Market Chameleon (Tue, 22-Sep 9:48 AM)

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Vertex Pharmaceuticals (VRTX)

at www.tipranks.com (Tue, 22-Sep 2:30 PM)

Vertex reports positive mid-stage results of inaxaplin for kidney disease

at seekingalpha.com (Tue, 22-Sep 11:24 AM)

Analysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Maze Therapeutics, Inc. (MAZE)

at www.tipranks.com (Tue, 22-Sep 10:40 AM)

FDA, Duke-Margolis workshop to examine evidence standards for rare diseases

at seekingalpha.com (Sun, 20-Sep 2:57 PM)